German industry demands tighter reconditioning laws
This article was originally published in Clinica
Executive Summary
If more efficient market surveillance reveals that those who process medical devices are unable to conform to the requirements, then we will have to consider further legal restrictions." This was the sentiment expressed by Hans Georg Will at last week's BVMed conference as he sought to tackle the problem of hospital in-house manufacturing and the reconditioning of medical devices in light of the second amendment of the medical device law (MPG - see this issue, p5).
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.